EBS Emergent BioSolutions Inc.

$7.98 -1.85%

Healthcare · Pharmaceutical Preparations

Emergent BioSolutions Inc. (EBS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $412 million. Shares last traded at $7.98, 43.1% below their 52-week high. Over the past year the stock is up 28.5%. EBS trades at a price-to-earnings ratio of 7.83, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 7.1%, above the peer median of -0.1%. Revenue declined 28.8% year over year.

Market Cap

$412M

Shares Out

51.6M

EPS (TTM)

$4.14

P/E Ratio

1.93

P/S Ratio

0.55

P/B Ratio

0.79

Dividend / Share

—

Dividend Yield

—

52-Week High

$14.04

52-Week Low

$5.61

Volume

45,447

Avg Vol (3m)

40,480.746

Performance

-4.89%

-1.05%

-1.12%

-34.64%

YTD

-36.26%

+28.50%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.02

SMA (50)

$8.42

SMA (200)

$9.71

Price vs SMA50

-5.26%

Price vs SMA200

-17.84%

ATR (14)

$0.53

Financials

Revenue

$743M

Net Income

$53M

Gross Margin

42.8%

Operating Margin

13.5%

Net Margin

7.1%

Return on Equity

10.1%

Return on Assets

4.0%

Current Ratio

4.29

Debt / Equity

1.13

Revenue Growth (YoY)

-28.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.07	2026-05-01
FY 2025	$0.93	2026-02-27
Q3 2025	$1.89	2025-10-30
Q2 2025	$0.99	2025-08-07
Q1 2026	$1.19	2026-05-01
FY 2025	$-3.60	2026-02-27

Full earnings history →

Pharmaceutical Preparations peers

EBS vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

7.83 / 16.82 med

-53% discount

P/S vs peers

0.55 / 3.54 med

-84% discount

Net margin vs peers

7.1% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.